Nutrient-restricted fetus and the cardio-renal connection in hypertensive offspring

Jeffrey S Gilbert1, Laura A Cox, Graham Mitchell

  • 1Department of Obstetrics and Gynecology, Center for Pregnancy and Newborn Research, University of Texas Health Science Center, San Antonio, TX 78229, USA. gilbertj@uthscsa.edu

Insights

A poor fetal environment increases offspring's risk for hypertension and cardiovascular disease. Research explores mechanisms and potential therapies for these developmental origins of disease.

Area of Science:

  • Developmental biology
  • Cardiovascular science
  • Public health

Background:

  • A suboptimal intrauterine environment negatively impacts fetal development and postpartum health.
  • Epidemiological studies link socioeconomic status and low birth weight to increased incidence of hypertension, diabetes, obesity, and cardiovascular disease.
  • Maternal stressors in animal models affect fetal development, leading to elevated offspring blood pressure.

Purpose of the Study:

  • To review recent research on the link between suboptimal intrauterine conditions and cardiovascular/renal phenotypes.
  • To refine hypotheses regarding the developmental origins of hypertension and cardiovascular disease.
  • To highlight the need for therapeutic strategies to mitigate these risks.

Main Methods:

  • Review of epidemiological and experimental studies.
  • Analysis of mechanisms contributing to hypertension (vascular dysfunction, altered cardio-renal function).
  • Examination of animal models of developmental hypertension.

Main Results:

  • Suboptimal intrauterine environments contribute to vascular dysfunction and altered cardio-renal structure/function in offspring.
  • These changes increase susceptibility to hypertension and cardiovascular disease.
  • Several mechanisms are implicated in the development of hypertension.

Conclusions:

  • A suboptimal intrauterine environment is a significant risk factor for developing hypertension and cardiovascular disease.
  • Understanding these developmental origins is crucial for identifying therapeutic targets.
  • Further research is needed to develop interventions to ameliorate these adverse outcomes.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...